Benralizumab
Showing 1 - 25 of 102
Asthma Trial in San Diego (Benralizumab-exposure, Exposure to other asthma medications)
Recruiting
- Asthma
- Benralizumab-exposure
- Exposure to other asthma medications
-
San Diego, CaliforniaResearch Site
Jan 20, 2023
Retrospective Study in UK Severe Asthma Centres
Completed
- Asthma
- Benralizumab
-
Cambridge, United Kingdom
- +7 more
Jun 28, 2023
Patient-Reported OUTcomes of Benralizumab in Real-World Use in
Not yet recruiting
- Severe Asthma
- (no location specified)
Nov 17, 2022
Asthma Trial in Worldwide (Benralizumab, Placebo)
Not yet recruiting
- Asthma
- Benralizumab
- Placebo
-
Owensboro, Kentucky
- +6 more
Jan 11, 2023
COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Benralizumab
- +2 more
- (no location specified)
Apr 26, 2022
Asthma Trial in Marseille, Montpellier (48 weeks of Benralizumab, Computed tomography)
Active, not recruiting
- Asthma
- 48 weeks of Benralizumab
- Computed tomography
-
Marseille, France
- +1 more
Sep 8, 2022
Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in United States (Benralizumab)
Recruiting
- Solid Tumor
- +3 more
- Benralizumab
-
Basking Ridge, New Jersey
- +4 more
Jan 18, 2023
Chronic Spontaneous Urticaria Trial in Worldwide (Benralizumab, Placebo and Benralizumab)
Active, not recruiting
- Chronic Spontaneous Urticaria
- Benralizumab
- Placebo and Benralizumab
-
Scottsdale, Arizona
- +39 more
Jan 16, 2023
Benralizumab in Real-World Use in Severe Eosinophilic Asthma
Recruiting
- Asthma
-
Changhua City, Taiwan
- +7 more
Feb 16, 2023
Malignancy in Severe Asthma Patients Receiving Benralizumab and
Recruiting
- Asthma
- Neoplasms
-
Stockholm, Sweden
- +1 more
Aug 8, 2022
Atopic Dermatitis Trial in Worldwide (Benralizumab, Placebo / Benralizumab)
Terminated
- Atopic Dermatitis
- Benralizumab
- Placebo / Benralizumab
-
Los Angeles, California
- +50 more
Jan 4, 2023
Real World Evidence of Benralizumab in Eosinophilic Severe
Recruiting
- Severe Eosinophilic Asthma
-
Moscow, Russian FederationCity clinical hospital No57
Aug 8, 2022
Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)
Not yet recruiting
- Asthma
- Benralizumab
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Apr 26, 2023
Eosinophilic Gastritis or Gastroenteritis Trial in Cincinnati (Benralizumab, Placebo)
Completed
- Eosinophilic Gastritis or Gastroenteritis
- Benralizumab
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 27, 2022
In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India Trial in India (Benralizumab)
Recruiting
- In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India
- Benralizumab
-
Bengaluru, India
- +12 more
Jan 3, 2023
Severe Uncontrolled Asthma Trial in Japan, United States (Benralizumab)
Completed
- Severe Uncontrolled Asthma
- Benralizumab
-
Los Angeles, California
- +14 more
Oct 7, 2022
Fluctuation Analyses of Asthma Patients With Biologics Use
Not yet recruiting
- Asthma
- Biological Drug
- (no location specified)
Sep 7, 2023
ABPA, Severe Asthma, Allergic Bronchopulmonary Aspergillosis Trial in Dallas (Fasenra, 30 Mg/mL Subcutaneous Solution)
Withdrawn
- ABPA
- +2 more
- Fasenra, 30 Mg/mL Subcutaneous Solution
-
Dallas, TexasBaylor University Medical Center
Jan 17, 2022
Nasal Polyps Trial in Rozzano (Benralizumab, Placebo)
Recruiting
- Nasal Polyps
- Benralizumab
- Placebo
-
Rozzano, MI, ItalyHumanitas Clinical and Research Hospital
Nov 17, 2021
Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)
Active, not recruiting
- Respiratory System Agents
- +4 more
- benralizumab
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022
Effect of Benralizumab on Airway Remodeling in Asthma
Recruiting
- Asthma
- Endobronchial biopsy
-
Bordeaux, FranceCIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
Nov 19, 2021
Severe Eosinophilic Asthma Treated With Benralizumab
Recruiting
- Asthma; Eosinophilic
-
Sevilla, SpainHospital Universitario Virgen Macarena
Nov 15, 2021
MRI and Lung Function Measures of Benralizumab Response in
Withdrawn
- Asthma
- (no location specified)
Nov 11, 2021
Asthma Trial in Worldwide (Benralizumab)
Recruiting
- Asthma
- Benralizumab
-
Denver, Colorado
- +38 more
Jan 18, 2023
Interaction Between Benralizumab and Basophils in Eosinophilic
Not yet recruiting
- Asthma; Eosinophilic
- BENRALIZUMAB
- (no location specified)
Aug 25, 2021